Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data ...

In an effort to become more nimble, some companies, like Bayer Pharmaceutical, are getting rid of middle managers.

Eton Pharmaceuticals is able to buy orphan drugs from large pharma companies, where they are too small to matter. Read why ...

Apellis Pharmaceuticals focuses on creating medicines targeting eye diseases and rare neurological diseases. Read why I rate ...

It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

This Philly-based company is using AI to predict which medical research can lead to profitable drugs and therapies Clarivate ...

Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's ...

Lilly—a manufacturer of medicines like Mounjaro, Zepbound and Ebglyss—is considering purchasing 236 acres from Generation ...

A new report from Impiricus and CMI finds that HCPs are looking for pharma to provide more educational support about clinical ...

An Enquirer analysis found that doctors, nurses and other practitioners received $136 million from pharma and biotech ...